ATLAS / Macro Radar / Reporting / VBIO

Valion Bio, Inc. (VBIO) reporting calendar

Valion Bio, Inc. files periodic reports with the SEC as VBIO on Nasdaq. Atlas tracks 18 filed reports for this issuer, each linked to its original EDGAR accession.

Next window
23 Jul 2026 – 5 Sep 2026
Latest report
10-Q
Period ended
31 Mar 2026
Filed
14 May 2026
Reports on record
18

How this window is derived. Derived from this issuer's own filing history: 9 periods at a median 91-day cadence, filed a median 45 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.

Open VBIO market profile Latest filing on SEC EDGAR ↗ Pharmaceutical Preparations reporting datesAll Nasdaq reporting dates

Filed periodic reports

FormPeriod endedFiledLagSEC accession
10-Q31 Mar 202614 May 202644 days0001437749-26-017142
10-K31 Dec 202530 Mar 202689 days0001437749-26-010343
10-Q30 Sep 202514 Nov 202545 days0001437749-25-035216
10-Q30 Jun 202514 Aug 202545 days0000950170-25-108977
10-Q31 Mar 202515 May 202545 days0000950170-25-072752
10-K31 Dec 202421 Mar 202580 days0000950170-25-043234
10-Q30 Sep 202414 Nov 202445 days0000950170-24-127072
10-Q30 Jun 202414 Aug 202445 days0000950170-24-097056
10-Q31 Mar 202415 May 202445 days0000950170-24-060534
10-K31 Dec 202325 Mar 202485 days0000950170-24-035946
10-Q30 Sep 202314 Nov 202345 days0000950170-23-063771
10-Q30 Jun 202314 Aug 202345 days0000950170-23-042520
10-Q31 Mar 202315 May 202345 days0000950170-23-022256
10-K31 Dec 202231 Mar 202390 days0000950170-23-011359
10-Q30 Sep 202214 Nov 202245 days0000950170-22-025033
10-Q30 Jun 202215 Aug 202246 days0001410578-22-002554
10-Q31 Mar 202216 May 202246 days0001410578-22-001666
10-K31 Dec 202131 Mar 202290 days0001104659-22-041068

Source: SEC EDGAR company submissions for CIK 0001787740. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.